(Q33694402)

28 July 2017

1 reference

title

Making the transition from hospital to home: caring for the newly diagnosed child with cancer (English)

1 reference

28 July 2017

Jacob E

1

1 reference

28 July 2017

publication date

1 April 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

4

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

67-73; quiz 74-5

1 reference

Transition from hospital to home for children with complex medical care

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

The child and family facing death

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Terminal care of the child with cancer at home

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Terminal care of the dying child. Psychosocial implications of care

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Home care for dying children: a nursing model

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Terminal care at home for children with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Home or hospital care for the child with end-stage cancer: effects on the family

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Home care for the dying child

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Home care for children dying of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Pain control in the terminally ill child at home

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Treatment of acute lymphoblastic leukemia. 30 years' experience at St. Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Ongoing challenges in pediatric hospice care.

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Pain medication during terminal care of children with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Planning and implementation of pediatric home care and hospice

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Home parenteral nutrition for the child with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Community-acquired bacteremias from tunneled central intravenous lines: results from studies of a single vendor

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Surveillance of intravenous catheter-related infections among home care clients

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Management of catheter-related infections in pediatric patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Fever in the pediatric and young adult patient with cancer. A prospective study of 1001 episodes.

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Management of fever in patients with cancer and treatment-induced neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Optimal growth of human blood hematopoietic progenitor cells collected by apheresis for autografts

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Effect of granulocyte colony-stimulating factor on chemotherapy-induced neutropenia in children with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Defective polymorphonuclear leukocyte functions in children receiving chemotherapy for cancer are partially restored by recombinant human granulocyte colony-stimulating factor in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Role of granulocyte colony-stimulating factor as adjunct therapy for septicemia in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Prophylactic administration of granulocyte colony-stimulating factor (filgrastim) after conventional chemotherapy in children with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Cost-minimization analysis of prophylactic granulocyte colony-stimulating factor after induction chemotherapy in children with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Safety and cost effectiveness of early hospital discharge of lower risk children with cancer admitted for fever and neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Approach to treatment of the febrile cancer patient with low-risk neutropenia.

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Outpatient parenteral therapy. Management of serious infections. Part I: Medical, socioeconomic, and legal issues. Selecting the patient

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Risk factors for recurrent fever after the discontinuation of empiric antibiotic therapy for fever and neutropenia in pediatric patients with a malignancy or hematologic condition

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Outpatient treatment of febrile episodes in low-risk neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Outpatient treatment of febrile neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Controversies in the management of febrile neutropenic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Home antibiotic therapy for low-risk cancer patients with fever and neutropenia: a pilot study of 30 patients based on a validated prediction rule

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of t

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Single daily dose ceftriaxone plus amikacin treatment of febrile episodes in neutropenic patients attending day hospital for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Pain management in home care

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Patient-controlled analgesia for chronic cancer pain in the ambulatory setting: a report of 117 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

The use of access devices in cancer pain control

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Ambulatory infusion pumps: application to oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Interleukin-2 toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

Nursing management of patients receiving biological therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1084-628X%2899%2990106-5

7 January 2021

10.1016/S1084-628X(99)90106-5

Identifiers

DOI

1 reference

28 July 2017

1 reference